BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32759565)

  • 1. [Acquired coagulation disorders].
    Suzuki N
    Rinsho Ketsueki; 2020; 61(7):779-784. PubMed ID: 32759565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupus anticoagulant-hypoprothrombinemia syndrome and immunoglobulin-A vasculitis: a report of Japanese sibling cases and review of the literature.
    Fujiwara K; Shimizu J; Tsukahara H; Shimada A
    Rheumatol Int; 2019 Oct; 39(10):1811-1819. PubMed ID: 31392497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time.
    Benzon HT; Park M; McCarthy RJ; Kendall MC; Lindholm PF
    Anesth Analg; 2019 Jun; 128(6):1089-1096. PubMed ID: 31094773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation Testing in the Core Laboratory.
    Winter WE; Flax SD; Harris NS
    Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lupus anticoagulant-hypoprothrombinemia syndrome associated with follicular lymphoma].
    Koyama D; Hanajiri R; Kanematsu T; Ito R; Yamamoto S; Imoto N; Suzuki N; Kurahashi S; Sugiura I
    Rinsho Ketsueki; 2020; 61(7):745-749. PubMed ID: 32759560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Acute Need Inspiration: Autoneutralization of Lupus Anticoagulants in Affected Prothrombin Times (PT) and Activated Partial Thromboplastin Times (APTT).
    Gosselin RC
    Methods Mol Biol; 2023; 2663():289-295. PubMed ID: 37204718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus anticoagulant-hypoprothrombinemia syndrome in children: Three case reports and systematic review of the literature.
    Sun YH; Nie WJ; Tian DD; Ye Q
    Lupus; 2023 Sep; 32(10):1211-1221. PubMed ID: 37480550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recurrent epistaxis with coagulation disorders in a boy aged 2 years].
    Li JZ; Tian X; Liao CS; He XL; Zhu CG
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jul; 24(7):817-820. PubMed ID: 35894199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lupus anticoagulant-hypoprothrombinemia syndrome with a false-positive test for coagulation factor inhibitors].
    Morinaga S; Ide Y; Kusumoto M; Ogata M; Takaki K; Matsumoto E
    Rinsho Ketsueki; 2012 Jul; 53(7):716-20. PubMed ID: 22975775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous inhibitors to coagulation factors.
    Green D
    Clin Lab Haematol; 2000 Oct; 22 Suppl 1():21-5; discussion 30-2. PubMed ID: 11251655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of coagulation time: PT and APTT].
    Ramakers C; van der Heul C; van Wijk EM
    Ned Tijdschr Geneeskd; 2012; 156(0):A3985. PubMed ID: 22917038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lupus anticoagulant-hypoprothrombinemia syndrome: A cerebral bleeding case report as systemic lupus erythematosus debut.
    Pérez ML; Laso RV; Velasco-Rodríguez D; Martín-Herrero S; Alfonzo IM; García-Raso A; Llamas-Sillero P
    Reumatol Clin (Engl Ed); 2023 Apr; 19(4):223-227. PubMed ID: 37061283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus anticoagulant-hypoprothrombinemia syndrome presenting with co-existing cerebral venous thrombosis and subdural hemorrhage.
    Bel Feki N; Zayet S; Ben Ghorbel I; Houman MH
    J Mal Vasc; 2016 Dec; 41(6):403-406. PubMed ID: 27743753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupus anticoagulant hypoprothrombinemia syndrome associated with systemic lupus erythematosus in children: report of two cases and systematic review of the literature.
    Pilania RK; Suri D; Jindal AK; Kumar N; Sharma A; Sharma P; Guleria S; Rawat A; Ahluwalia J; Singh S
    Rheumatol Int; 2018 Oct; 38(10):1933-1940. PubMed ID: 30099593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric systemic lupus erythematosus with lupus anticoagulant hypoprothrombinemia syndrome-A case series with review of literature.
    Kocheril AP; Vettiyil GI; George AS; Shah S; Geevar T; Dave RG; T SK
    Lupus; 2021 Apr; 30(4):641-648. PubMed ID: 33509039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review of the presentation of coagulation factor VIII inhibitors in rheumatic diseases: A potential cause of life-threatening hemorrhage.
    O'Connor CR
    Semin Arthritis Rheum; 2015 Jun; 44(6):695-709. PubMed ID: 25595725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test.
    Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Aoki T
    Thromb Res; 2014 Aug; 134(2):503-9. PubMed ID: 24935674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Importance of Quick, partial thromboplastin time, and Co].
    Siegert G
    Internist (Berl); 2014 May; 55(5):506, 508, 510-3. PubMed ID: 24781934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!
    Santoro RC; Molinari AC; Leotta M; Martini T
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cross-mixing test to detect lupus anticoagulant for diagnosis of antiphospholipid syndrome].
    Ieko M; Naito S; Yoshida M
    Rinsho Byori; 2009 Oct; 57(10):990-8. PubMed ID: 19928497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.